The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients

Aims: One of the proposed limitations of left ventricular assist device (LVAD) therapy is high degree of sensitization. Apart from human leukocyte antigen (HLA), antibodies against Angiotensin II Type 1 Receptor (AT1R) have been associated with adverse outcomes. The purpose of this study was to comp...

Full description

Bibliographic Details
Main Authors: Marian Urban, Antonij Slavcev, Tomas Gazdic, Peter Ivak, Ivan Netuka
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2016-12-01
Series:Biomedical Papers
Subjects:
Online Access:https://biomed.papers.upol.cz/artkey/bio-201604-0010_The_impact_of_Angiotensin_II_Type_1_Receptor_antibodies_on_morbidity_and_mortality_in_Heart_Mate_II_supported_r.php